Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Tusaldah Ltd.
Source DateBoard Meeting DateDetails
09-Feb-2026 12-Feb-2026 Quarterly Results
11-Nov-2025 14-Nov-2025 Quarterly Results
07-Aug-2025 13-Aug-2025 Voluntary Delisting of Shares & Quarterly Results
20-Jun-2025 26-Jun-2025 Inter alia, to consider and approve :- 1. To consider and approve the appointment of Additional Directors of the Company; 2. To consider and approve the resignation of Directors of the Company; 3. To consider and approve the Reclassification of Outgoing Promoters on account of open offer; 4. To consider and approve the appointment of Company Secretary and Compliance officer of the Company; 5. To consider and approve the Change of name of the Company; 6. To consider and approve the Shifting of Registered Office from the State of Rajasthan to the State of Maharashtra; 7. To consider and approve the appointment of Statutory Auditor of the Company for the year 2025-26; 8. To consider and approve the appointment of Internal Auditor of the Company for the year 2025-26; 9. Any other matter with the permission of the Chair.
19-May-2025 24-May-2025 Audited Results
27-Jan-2025 03-Feb-2025 Quarterly Results
17-Jan-2025 24-Jan-2025 Inter alia, to consider and approve:- 1. To discuss and consider alteration in the Articles of Association of the Company subject to approval of shareholders. 2. To discuss and consider increase in Authorized Share Capital of the Company subject to approval of shareholders. 3. The proposal for fund raising by way of preferential issue / private placement of securities for cash, including determination of Issue Price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.; 4. To discuss and consider alteration of main object clause of the Memorandum of Association of the Company, subject to approval of shareholders; 5. To discuss and consider the shifting of registered office of the Company. 6. To discuss and consider Borrowing money in excess of paid-up share capital, free reserves, and securities premium under Section 180(1)(c) of the Companies Act, 2013.
05-Nov-2024 12-Nov-2024 Quarterly Results
01-Aug-2024 09-Aug-2024 Quarterly Results
17-May-2024 08-May-2024
02-May-2024 08-May-2024 Audited Results
20-Jan-2024 29-Jan-2024 Increase in Authorised Capital & Preferential Issue of shares & Quarterly Results
30-Oct-2023 06-Nov-2023 Quarterly Results
27-Jul-2023 04-Aug-2023 Quarterly Results
17-May-2023 25-May-2023 Audited Results
02-Feb-2023 10-Feb-2023 Quarterly Results
07-Nov-2022 12-Nov-2022 Quarterly Results
03-Aug-2022 12-Aug-2022 Quarterly Results
17-May-2022 25-May-2022 Audited Results
31-Jan-2022 10-Feb-2022 Quarterly Results
Page 1 of 5
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.